» Articles » PMID: 22605725

AIDS Research. FDA Panel Recommends Anti-HIV Drug for Prevention

Overview
Journal Science
Specialty Science
Date 2012 May 19
PMID 22605725
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections.

Tyo K, Lasnik A, Zhang L, Mahmoud M, Jenson A, Fuqua J J Control Release. 2020; 321:84-99.

PMID: 32035194 PMC: 7170769. DOI: 10.1016/j.jconrel.2020.02.006.


Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection.

Duwal S, Schutte C, von Kleist M PLoS One. 2012; 7(7):e40382.

PMID: 22808148 PMC: 3394807. DOI: 10.1371/journal.pone.0040382.